Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.360
+0.130 (5.83%)
At close: Feb 19, 2026, 4:00 PM EST
2.350
-0.010 (-0.42%)
After-hours: Feb 19, 2026, 5:57 PM EST
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
105
Market Cap
167.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Spero Therapeutics | 40.55M |
| Sangamo Therapeutics | 32.88M |
| Whitehawk Therapeutics | 14.38M |
| Caribou Biosciences | 9.30M |
| Fate Therapeutics | 7.14M |
| Connect Biopharma Holdings | 762.00K |
NKTX News
- 2 months ago - Nkarta to Participate in Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha
- 3 months ago - Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - Nkarta to Participate in November Investor Conferences - GlobeNewsWire
- 4 months ago - Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - GlobeNewsWire
- 6 months ago - Nkarta to Participate in a September Investor Conference - GlobeNewsWire
- 6 months ago - Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 7 months ago - Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewsWire